OTC Markets EXMKT - Delayed Quote USD
Eagle Pharmaceuticals, Inc. (EGRX)
1.7000
-0.2700
(-13.71%)
At close: April 25 at 2:56:53 PM EDT
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
406,160
253,732
253,190
Total Liabilities Net Minority Interest
172,600
77,279
67,179
Total Equity Gross Minority Interest
233,560
176,453
186,011
Total Capitalization
289,776
176,453
211,146
Common Stock Equity
233,560
176,453
186,011
Capital Lease Obligations
1,534
1,309
1,123
Net Tangible Assets
70,200
126,039
133,351
Working Capital
77,667
98,230
127,980
Invested Capital
296,026
202,060
219,146
Tangible Book Value
70,200
126,039
133,351
Total Debt
64,000
26,916
34,258
Net Debt
7,145
--
--
Share Issued
17,569.3750
16,903.0340
16,739.2030
Ordinary Shares Number
13,016.6450
12,791.4120
13,057.0270
Treasury Shares Number
4,552.7300
4,111.6220
3,682.1760
12/31/2020 - 2/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COLL Collegium Pharmaceutical, Inc.
26.79
+0.04%
ANIP ANI Pharmaceuticals, Inc.
69.82
+0.26%
INNPF InnoCan Pharma Corporation
0.1400
0.00%
MRKC.F Merck KGaA
23.60
0.00%
MKGAF Merck KGaA
138.65
+1.02%
ALKS Alkermes plc
27.84
+0.61%
PCRX Pacira BioSciences, Inc.
25.72
-1.08%
CPIX Cumberland Pharmaceuticals Inc.
4.9700
+2.58%
EBS Emergent BioSolutions Inc.
5.49
+2.23%
PRFX PainReform Ltd.
2.3500
+1.29%